Basket cover image
16 handpicked stocks

Market Indecision

Find refuge from market volatility with these carefully selected companies providing essential goods and services. Our professional analysts have handpicked high-quality, dividend-paying stocks in defensive sectors that offer stability when economic futures look uncertain.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+6

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जून 18

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

PG

Procter & Gamble Company, The

PG

Current price

$158.40

Its vast portfolio of essential household and personal care products ensures consistent demand regardless of economic conditions.

KO

Coca-Cola Company, The

KO

Current price

$70.13

As a global beverage giant with unparalleled brand loyalty, it offers stable revenue and a long history of dividend payments.

JNJ

Johnson & Johnson

JNJ

Current price

$177.80

A diversified healthcare giant with strong segments in pharmaceuticals, medical devices, and consumer health, offering market resilience.

About This Group of Stocks

1

Our Expert Thinking

These stocks represent companies providing life's necessities that remain in demand regardless of economic conditions. When markets feel unpredictable, these businesses offering essential consumer products, utilities, and healthcare services typically demonstrate greater resilience and lower volatility.

2

What You Need to Know

This collection features established industry leaders with predictable revenue streams and strong dividend histories. These stocks generally won't deliver explosive growth, but they aim to provide more stable returns, reduce portfolio volatility, and generate consistent income through reliable dividend payments.

3

Why These Stocks

Each company was selected for its non-cyclical demand patterns, proven financial stability, and commitment to shareholder returns. In today's climate of economic uncertainty and market fluctuations, these defensive selections offer the predictability and income potential many investors seek.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+4.75%

Group Performance Snapshot

4.75%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 4.75% over the next year.

11 of 16

Stocks Rated Buy by Analysts

11 of 16 assets in this group are rated Buy by professional analysts.

2.7%

Group Growth

This group averaged a 2.7% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

💰

Income You Can Count On

These companies are known for their reliable dividend payments, providing steady income even when market prices fluctuate. Many have histories of increasing dividends year after year.

🛡️

Sleep-Better Portfolio Protection

When markets get choppy, these essential businesses tend to hold their value better than most. They sell products people need regardless of economic conditions.

🧘

Less Drama, More Stability

If market swings make you anxious, these stocks typically experience lower price volatility than the broader market, offering a smoother investment experience during uncertain times.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Orphan Drug Moats: Leaders In Rare Disease

Orphan Drug Moats: Leaders In Rare Disease

The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.

View stocks
Nvidia's China Chip Pivot

Nvidia's China Chip Pivot

Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.

View stocks
Navigating The Autonomous Driving Shakeout

Navigating The Autonomous Driving Shakeout

A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.